A digital view of the world illustrates how Astellas is a global company committed to serving patients worldwide.

News

Astellas is committed to providing timely and accurate information about our business, science and products. This section offers global resources for investors, journalists and media professionals. News and resources from our local affiliates can be viewed in the Local news section. If you are not an investor or journalist, click here.

New treatment for the management of advanced prostate cancer after failure on first-line hormonal treatments and docetaxel chemotherapy, now available for use in the UK
Jul 11, 2013
Prostate cancer is the most common cancer amongst males in the UK,ii with approximately 40,000 new cases diagnosed every yearii